MIDATECH PHARMA
R&D | Pipeline

Pipeline of product candidates in clinical and pre-clinical development in key therapeutic areas.

Midatech is advancing a pipeline of product candidates in clinical and pre-clinical development for diseases for which there are currently few or no treatment options available. These diseases include rare cancers such as brain (glioblastoma), liver cancer and autoimmune conditions such as diabetes and uveitis. A pipeline of currently ten projects is underway from discovery through to Phase I/II in these indications.

 

 

R&D
R&D
Pipeline

Pipeline of product candidates in clinical and pre-clinical development in key therapeutic areas.

Midatech is advancing a pipeline of product candidates in clinical and pre-clinical development for diseases for which there are currently few or no treatment options available. These diseases include rare cancers such as brain (glioblastoma), liver cancer and autoimmune conditions such as diabetes and uveitis. A pipeline of currently ten projects is underway from discovery through to Phase I/II in these indications.

 

 

© Copyright 2017 Midatech Pharma PLC